- Home
- SCHW vs BSX Comparison
SCHW vs BSX Comparison
Compare SCHW & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCHW
- BSX
- Stock Information
- Founded
- SCHW 1971
- BSX 1979
- Country
- SCHW United States
- BSX United States
- Employees
- SCHW N/A
- BSX N/A
- Industry
- SCHW Investment Bankers/Brokers/Service
- BSX Medical/Dental Instruments
- Sector
- SCHW Finance
- BSX Health Care
- Exchange
- SCHW Nasdaq
- BSX Nasdaq
- Market Cap
- SCHW 151.5B
- BSX 129.7B
- IPO Year
- SCHW 1987
- BSX 1992
- Fundamental
- Price
- SCHW $74.30
- BSX $89.09
- Analyst Decision
- SCHW Buy
- BSX Strong Buy
- Analyst Count
- SCHW 15
- BSX 23
- Target Price
- SCHW $81.00
- BSX $96.41
- AVG Volume (30 Days)
- SCHW 7.7M
- BSX 4.6M
- Earning Date
- SCHW 01-15-2025
- BSX 01-29-2025
- Dividend Yield
- SCHW 1.35%
- BSX N/A
- EPS Growth
- SCHW N/A
- BSX 47.19
- EPS
- SCHW 2.56
- BSX 1.21
- Revenue
- SCHW $18,736,000,000.00
- BSX $15,911,000,000.00
- Revenue This Year
- SCHW $4.98
- BSX $17.57
- Revenue Next Year
- SCHW $11.54
- BSX $12.29
- P/E Ratio
- SCHW $29.03
- BSX $73.58
- Revenue Growth
- SCHW N/A
- BSX 15.66
- 52 Week Low
- SCHW $59.67
- BSX $55.60
- 52 Week High
- SCHW $83.35
- BSX $91.93
- Technical
- Relative Strength Index (RSI)
- SCHW 34.13
- BSX 46.40
- Support Level
- SCHW $80.95
- BSX $89.49
- Resistance Level
- SCHW $83.30
- BSX $91.59
- Average True Range (ATR)
- SCHW 1.86
- BSX 1.40
- MACD
- SCHW -1.32
- BSX -0.35
- Stochastic Oscillator
- SCHW 9.82
- BSX 23.79
About SCHW Charles Schwab Corporation (The)
Charles Schwab operates in brokerage, wealth management, banking, and asset management. It runs a large network of brick-and-mortar brokerage branch offices and a well-established online investing website, and it has mobile trading capabilities. It also operates a bank and a proprietary asset-management business and offers services to independent investment advisors. Schwab is among the largest firms in the investment business, with over $8 trillion of client assets at the end of December 2023. Nearly all of its revenue is from the United States.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.